Market Price

0.97 

0.02 2.1%

as of May 20 '22

52 Week Range:

0.72 1.30


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Ausnutria Dairy Corporation Ltd, an investment holding company, primarily engages in the research and development, milk collection, processing, production, packaging, marketing, and distribution of infant formula and other dairy products. The company operates in two segments, Dairy and Related Products, and Nutrition Products. It offers cow milk based formula products under the Allnutria, A-Choice, BestChoice, Hyproca 1897, Puredo, Mygood, and Eurlate brand names; and goat milk based infant formula products under the Kabrita brand. The company also produces formula milk powder products on an OEM basis. In addition, it engages in the research and development, manufacturing, packaging, marketing, and distribution of complementary medicine, and nutritional and health care products under the Nutrition Care and Brighthope brand names, as well as provision of contract manufacturing services. The company operates in the People's Republic of China, the Netherlands, Australia, New Zealand, the Middle East, North America, Russia and the Commonwealth of Independent States, and internationally. Ausnutria Dairy Corporation Ltd was founded in 2003 and is based in Central, Hong Kong.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 0.13
0.16
0.13
0.15
0.17
0.14
0.27
0.30
0.42
growth rate 7.2% -18.8% 15.4% 13.3% -17.7% 92.9% 11.1% 40.0%
Earnings BIT 141.25
115.00
-29.03
256.94
398.07
729.45
1,203.19
1,180.11
1,274.50
growth rate -18.6% -100.0% 100.0% 54.9% 83.3% 65.0% -1.9% 8.0%
Avg.PE 55.86
15.28
21.07
15.61
15.61
15.61
15.61
growth rate -72.7% 37.9% -25.9% 0.0% 0.0% 0.0%
ROA 3.23
4.25
6.72
4.07
1.85
6.12
6.46
10.20
11.58
11.42
11.09
growth rate 31.6% 58.1% -39.4% -54.6% 230.8% 5.6% 57.9% 13.5% -1.4% -2.9%
ROE 4.29
6.94
11.51
8.14
4.18
15.30
19.21
25.43
24.17
21.86
19.43
growth rate 61.8% 65.9% -29.3% -48.7% 266.0% 25.6% 32.4% -5.0% -9.6% -11.1%
ROIC 3.09
5.09
8.46
5.18
1.86
7.98
9.38
15.88
18.50
17.47
15.77
growth rate 64.7% 66.2% -38.8% -64.1% 329.0% 17.5% 69.3% 16.5% -5.6% -9.7%
Cur. Ratio 2.59
2.68
2.06
1.56
1.49
1.39
1.17
1.56
1.65
1.58
1.70
growth rate 3.5% -23.1% -24.3% -4.5% -6.7% -15.8% 33.3% 5.8% -4.2% 7.6%
Quick Ratio 1.88
2.13
1.24
0.87
0.52
0.47
0.36
0.71
0.72
0.71
0.85
growth rate 13.3% -41.8% -29.8% -40.2% -9.6% -23.4% 97.2% 1.4% -1.4% 19.7%
Leverage 1.66
1.61
1.80
2.20
2.31
2.67
3.23
2.10
2.08
1.79
1.72
growth rate -3.0% 11.8% 22.2% 5.0% 15.6% 21.0% -35.0% -1.0% -13.9% -3.9%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 195.00
257.95
259.11
298.34
334.60
265.69
429.72
514.76
602.31
602.32
growth rate 32.3% 0.5% 15.1% 12.2% -20.6% 61.7% 19.8% 17.0% 0.0%
Acct.Payable 105.00
167.95
184.22
172.69
151.93
271.93
283.58
337.94
409.25
405.98
growth rate 60.0% 9.7% -6.3% -12.0% 79.0% 4.3% 19.2% 21.1% -0.8%
Cur.Assets 1,182.00
1,490.76
1,750.24
2,193.42
2,537.04
3,219.08
4,138.55
4,974.21
5,362.53
5,632.33
growth rate 26.1% 17.4% 25.3% 15.7% 26.9% 28.6% 20.2% 7.8% 5.0%
Total Assets 1,588.00
2,002.70
2,433.27
3,030.52
3,923.65
5,621.13
6,829.01
8,343.19
9,247.96
9,514.21
growth rate 26.1% 21.5% 24.6% 29.5% 43.3% 21.5% 22.2% 10.8% 2.9%
Cash 283.00
161.16
278.28
307.62
546.53
635.65
1,449.86
1,674.54
1,857.52
2,262.19
growth rate -43.1% 72.7% 10.5% 77.7% 16.3% 128.1% 15.5% 10.9% 21.8%
Inventory 191.00
315.65
515.56
579.86
800.26
1,083.39
1,544.32
2,051.33
2,400.95
2,198.47
growth rate 65.3% 63.3% 12.5% 38.0% 35.4% 42.6% 32.8% 17.0% -8.4%
Cur.Liabilities 441.00
722.69
1,121.70
1,474.33
1,828.59
2,763.24
2,653.16
3,012.95
3,392.67
3,316.31
growth rate 63.9% 55.2% 31.4% 24.0% 51.1% -4.0% 13.6% 12.6% -2.3%
Liabilities 525.00
808.24
1,218.34
1,702.98
2,334.00
3,674.12
3,434.46
4,279.29
4,096.02
4,020.56
growth rate 54.0% 50.7% 39.8% 37.1% 57.4% -6.5% 24.6% -4.3% -1.8%
LT Debt 38.00
36.59
31.42
174.63
440.28
609.21
246.83
590.32
401.70
490.47
growth rate -3.7% -14.1% 455.8% 152.1% 38.4% -59.5% 139.2% -32.0% 22.1%
Equity 1,109.81
1,107.76
1,312.68
1,468.07
1,740.49
3,253.74
4,015.65
5,171.37
5,538.54
growth rate -0.2% 18.5% 11.8% 18.6% 86.9% 23.4% 28.8% 7.1%
Common Shares 995.00
987.00
987.00
987.00
1,033.00
1,250.00
1,265.00
1,362.00
1,612.00
1,658.00
1,723.00
growth rate -0.8% 0.0% 0.0% 4.7% 21.0% 1.2% 7.7% 18.4% 2.9% 3.9%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 40.00
126.74
206.50
157.24
248.11
469.84
307.03
247.48
439.89
442.32
growth rate 216.8% 62.9% -23.9% 57.8% 89.4% -34.7% -19.4% 77.8% 0.6%
Cash Dividends 77.59
77.59
33.59
33.59
53.86
106.92
207.89
322.41
388.16
growth rate 0.0% -56.7% 0.0% 60.4% 98.5% 94.4% 55.1% 20.4%
Cash From OA 168.00
82.62
85.88
-45.45
294.41
512.46
531.81
970.79
1,130.22
1,071.32
growth rate -50.8% 3.9% -100.0% 100.0% 74.1% 3.8% 82.6% 16.4% -5.2%
FCF per Share 0.01
-0.01
-0.02
-0.02
0.01
-0.01
0.03
0.08
-0.01
growth rate -100.0% 0.0% 0.0% 100.0% -100.0% 100.0% 166.7% -100.0%
Sale Purchase of Stock 208.44
208.44
208.44
17.58
17.58
growth rate 0.0% 0.0% -91.6% 0.0%
FCF 103.00
125.00
-53.00
-128.00
-211.00
10.00
-7.00
171.00
674.00
624.00
515.00
growth rate 21.4% -100.0% 0.0% 0.0% 100.0% -100.0% 100.0% 294.2% -7.4% -17.5%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 1,351.00
1,687.78
1,966.05
2,103.53
2,740.26
3,926.47
5,389.57
6,736.15
7,985.82
8,873.27
growth rate 24.9% 16.5% 7.0% 30.3% 43.3% 37.3% 25.0% 18.6% 11.1%
Op.Income 68.00
141.25
115.00
-29.03
256.94
398.07
729.45
1,203.19
1,180.11
1,274.50
growth rate 107.7% -18.6% -100.0% 100.0% 54.9% 83.3% 65.0% -1.9% 8.0%
IBT 157.80
137.27
3.79
297.75
438.55
791.99
1,107.18
1,220.85
1,233.65
growth rate -13.0% -97.2% 7,754.2% 47.3% 80.6% 39.8% 10.3% 1.1%
Net Income 68.00
120.71
90.22
50.65
212.67
308.13
635.10
878.39
1,004.11
1,040.26
growth rate 77.5% -25.3% -43.9% 319.9% 44.9% 106.1% 38.3% 14.3% 3.6%
EPS 0.04
0.07
0.12
0.09
0.05
0.17
0.24
0.47
0.55
0.61
0.60
growth rate 75.0% 71.4% -25.0% -44.4% 240.0% 41.2% 95.8% 17.0% 10.9% -1.6%
Gross Profit 326.00
471.76
567.21
589.97
1,124.86
1,690.20
2,660.64
3,533.32
3,981.96
4,470.73
growth rate 44.7% 20.2% 4.0% 90.7% 50.3% 57.4% 32.8% 12.7% 12.3%

Quarterly Statements

Item Name Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Earnings BIT 402.86
384.68
299.31
295.26
295.26
growth rate -4.5% -22.2% -1.4% 0.0%
Balance Sheet Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Acct.Receivable 602.31
506.80
602.32
602.32
growth rate -8.3% 18.9% 0.0%
Acct.Payable 409.25
485.14
405.98
405.98
growth rate 8.9% -16.3% 0.0%
Cur.Assets 5,362.53
5,065.44
5,632.33
5,632.33
growth rate -2.8% 11.2% 0.0%
Total Assets 9,247.96
8,960.17
9,514.21
9,514.21
growth rate -1.6% 6.2% 0.0%
Cash 1,857.52
1,428.92
2,262.19
2,262.19
growth rate -12.3% 58.3% 0.0%
Inventory 2,400.95
2,464.32
2,198.47
2,198.47
growth rate 1.3% -10.8% 0.0%
Cur.Liabilities 3,392.67
3,150.39
3,316.31
3,316.31
growth rate -3.6% 5.3% 0.0%
Liabilities 4,096.02
3,764.17
4,020.56
4,020.56
growth rate -4.1% 6.8% 0.0%
LT Debt 401.70
298.86
490.47
490.47
growth rate -13.8% 64.1% 0.0%
Equity 5,171.37
5,171.37
5,227.05
5,538.54
5,538.54
growth rate 0.0% 1.1% 6.0% 0.0%
Common Shares 149.27
149.49
149.49
149.49
growth rate 0.1% 0.0% 0.0%
Cash Flow Statement Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Capital Expenditures 138.77
138.77
138.77
138.77
growth rate 0.0% 0.0% 0.0%
Cash Dividends 0.05
0.05
0.05
0.05
growth rate 0.0% 0.0% 0.0%
Cash From OA 485.64
485.64
485.64
485.64
growth rate 0.0% 0.0% 0.0%
FCF 346.88
346.88
346.88
346.88
growth rate 0.0% 0.0% 0.0%
Income Statement Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Sales 2,228.19
2,183.33
2,087.22
2,301.36
2,301.36
growth rate -2.0% -4.4% 10.3% 0.0%
Op.Income 402.86
384.68
299.31
295.26
295.26
growth rate -4.5% -22.2% -1.4% 0.0%
IBT 337.60
389.00
309.21
267.72
267.72
growth rate 15.2% -20.5% -13.4% 0.0%
Net Income 291.90
331.43
262.56
223.14
223.14
growth rate 13.5% -20.8% -15.0% 0.0%
Gross Profit 1,076.36
1,115.80
1,020.60
1,167.16
1,167.16
growth rate 3.7% -8.5% 14.4% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (82.94)

YOY Growth Grade:

C (54.36)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 15.61 17.02
EPS / Growth 0.06

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 22.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 22.9% 22.9% 22.9%
Future PE 0.01 10.41 20.47
Future EPS 0.45 0.45 0.45
Value Price
MOS %
0.00
-99.9%
1.15
18.8%
2.27
133.5%
MOS Price 0.00 0.58 1.13
IRT 6.92 6.92 6.92

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.